| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 08/04/2004 | EP1140021B1 Improved formulation for topical non-invasive application in vivo |
| 08/04/2004 | EP1124829B1 Tricyclic phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 08/04/2004 | EP1112262B1 Substituted gamma-phenyl-delta-lactones and analogs thereof and uses related thereto |
| 08/04/2004 | EP1076657B1 New hydroxyindoles, their use as phosphodiesterase 4 inhibitors and method for producing same |
| 08/04/2004 | CN1518552A Pyrrolopyrimidines as protein kinase inhitibors |
| 08/04/2004 | CN1518551A Triazaspiro [5,5] undecane derivatrives and drugs containing the same as active ingredient |
| 08/04/2004 | CN1518549A Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 08/04/2004 | CN1518542A Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes |
| 08/04/2004 | CN1518463A Safety shield system for prefilled syringes |
| 08/04/2004 | CN1518460A Composition comprising PDE-4 inhibitor and H1-receptor antagonist and use thereof for manufacture of medicament for treatment of respiratory diseases |
| 08/04/2004 | CN1518459A Remedies for eosinophilic diseases |
| 08/04/2004 | CN1518451A Identifying and treatment of purastic fungi of organism |
| 08/04/2004 | CN1518448A Antihistamines for treatment of nasal congestion and nasal obstruction |
| 08/04/2004 | CN1160359C Dithiepino [6,5-b] pyridines, and related compsns. and methods for preparing and use |
| 08/04/2004 | CN1160357C Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl acetic acid |
| 08/04/2004 | CN1160355C Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof |
| 08/04/2004 | CN1160344C Compounds for treatment of asthma, allergy and inflammatory disorders and its use |
| 08/04/2004 | CN1160312C Substituted alkyl tetramine dervative |
| 08/04/2004 | CN1160123C Use of ulinastatin in treating SARS and medicinal composition thereof |
| 08/04/2004 | CN1160112C Therapeutic liquid for common cold and rhinits and its preparing method and use |
| 08/04/2004 | CN1160104C Traditional chinese medicine compostion with blood-enrich, tonifying Qi and warming kidney function |
| 08/04/2004 | CN1159984C Prophylactic dietary supplement based on milk |
| 08/03/2004 | US6770656 Amine derivatives for the treatment of apoptosis |
| 08/03/2004 | US6770654 Indole derivatives and use thereof in medicines |
| 08/03/2004 | US6770651 A2B adenosine receptor antagonists |
| 08/03/2004 | US6770646 Substituted fused pyridazinone compounds; composition and use thereof |
| 08/03/2004 | US6770643 Inhibit protein kinases |
| 08/03/2004 | US6770637 Substituted 4-phenyl-pyridine compounds with activity as antagonists of neurokinin 1 receptors |
| 08/03/2004 | US6770626 Amino acid sequence from certain regions of tissue growth factor-beta super family serine-threonine kinase receptors |
| 08/03/2004 | US6770620 Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders |
| 08/03/2004 | US6770619 Lung surfactant compositions with dynamic swelling behavior |
| 08/03/2004 | US6770267 Methods of treating periodontal disease |
| 07/29/2004 | WO2004063748A1 Method of screening agonist or antagonist to thyroxine receptor |
| 07/29/2004 | WO2004063202A1 Fused furan compound |
| 07/29/2004 | WO2004062686A2 Therapeutic use of modulators of notch |
| 07/29/2004 | WO2004062656A1 Compositions and methods for improving the condition of patients suffering from copd and other diseases |
| 07/29/2004 | WO2004062603A2 Methods of treating lung diseases |
| 07/29/2004 | WO2004062551A2 RECOMBINANT VHH SINGLE DOMAIN ANTIBODY FROM CAMELIDAE AGAINST VON WILLEBRAND FACTOR (vWF) OR AGAINST COLLAGEN |
| 07/29/2004 | WO2004050070A3 Composition comprising pseudoephedrine and domperidone for preventing snoring |
| 07/29/2004 | WO2004041296A3 Pharmaceutical composition comprising a tissue factor antagonist and protein c polypeptides |
| 07/29/2004 | WO2004037768A3 Phenethanolamine derivatives |
| 07/29/2004 | WO2004014913A3 Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors |
| 07/29/2004 | WO2004012686A3 Nitrosated and/or nitrosylated ursodeoxycholic acid compounds, compositions and methods of use |
| 07/29/2004 | WO2004010972A3 Pellicle-resistant gelatin capsule |
| 07/29/2004 | WO2003094861A3 Bis-benzimidazoles and related compounds as potassium channel modulators |
| 07/29/2004 | WO2003086317A3 Protein a compositions and methods of use |
| 07/29/2004 | WO2003075741A3 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE |
| 07/29/2004 | WO2003068803A3 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 07/29/2004 | WO2003040107A8 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity |
| 07/29/2004 | WO2002069883A3 Cathecin derivatives as leukocyte elastase inhibitors for treating inflammatory disorders |
| 07/29/2004 | US20040147759 Enzyme inhibitors as antiinflammatory agents or muscle relaxants |
| 07/29/2004 | US20040147745 Novel compounds and compositions as protease inhibitors |
| 07/29/2004 | US20040147724 for diagnosis/treatment of cancer, myeloproliferative disorders, angiogenesis, obesity, osteoporosis, non-insulin dependent diabetes, lipid metabolism disorder, hypercalcemia, hypercholestrolemia; genetic engineering |
| 07/29/2004 | US20040147614 Serotonin receptor antagonist; administering reboxetine; psychological disorders |
| 07/29/2004 | US20040147609 Liquid drug preparations |
| 07/29/2004 | US20040147606 Medicinal compositions |
| 07/29/2004 | US20040147605 Mixture of antitussive agent and fudosteine |
| 07/29/2004 | US20040147587 Compounds for the modulation of the glycolysis enzyme and/or transaminase complex |
| 07/29/2004 | US20040147577 Heterocyclic compounds |
| 07/29/2004 | US20040147573 Metalloproteinase inhibitors |
| 07/29/2004 | US20040147570 Substituted 1 and 2-naphthol mannich bases |
| 07/29/2004 | US20040147563 Use of thiazole deirvatives for the manufacture of a medicament for the treatment of chronic obstructive pulmonary disease |
| 07/29/2004 | US20040147562 Controlling cell gene expression; moderate cell proliferation; anticancer agents; antiinflammatory agents; cardiovascular disorders; autoimmune disease |
| 07/29/2004 | US20040147556 Analgesics; anxiolytuic agents; gastrointestinal disorders |
| 07/29/2004 | US20040147553 Efficiency; side effect reduction; antiarthriutic agents; autoimmune diseases |
| 07/29/2004 | US20040147544 Pde4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases |
| 07/29/2004 | US20040147542 Chemical compounds |
| 07/29/2004 | US20040147525 Antiinflammatory agents; analgesics; antiarthritic agents |
| 07/29/2004 | US20040147520 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists |
| 07/29/2004 | US20040147519 Sulfonylquinoxalone acetamide derivatives as bradykinin antagonists |
| 07/29/2004 | US20040147512 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/29/2004 | US20040147505 Neurodegradative diseases; antiinflammatory agents; analgesics; drug abuse |
| 07/29/2004 | US20040147495 Sapogenin derivatives, their synthesis and use, and methods based upon their use |
| 07/29/2004 | US20040147490 Immunosuppressants |
| 07/29/2004 | US20040147485 Antiinflammatory agents; antiischemic agents; antiarthritic agents; antihistamines; multiple sclerosis; Alzheimer's disease; Huntington's disease; parkinson's disease; antiepileptic agents; headaches |
| 07/29/2004 | US20040147468 Immunostimulatory nucleic acid molecules |
| 07/29/2004 | US20040147010 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative, potential pathogenic gram-positive bacteria |
| 07/29/2004 | US20040146508 Use of cd25 binding molecules in steroid-resistant patients |
| 07/29/2004 | US20040146504 Anti-IgE vaccines |
| 07/29/2004 | CA2512672A1 Methods of treating lung diseases |
| 07/29/2004 | CA2512545A1 Recombinant vhh single domain antibody from camelidae against von willebrand factor (vwf) |
| 07/28/2004 | EP1440976A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 07/28/2004 | EP1440966A1 Indole derivatives useful for the treatment of diseases |
| 07/28/2004 | EP1440686A1 Aerosol compositions |
| 07/28/2004 | EP1440161A2 7118, a human arginine n-methyltransferase family member and uses therefor |
| 07/28/2004 | EP1440083A2 Molecules |
| 07/28/2004 | EP1440073A1 Pde9 inhibitors for treating cardiovascular disorders |
| 07/28/2004 | EP1440062A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles |
| 07/28/2004 | EP1440052A1 Benzamide derivatives as antagonists of orexin receptors |
| 07/28/2004 | EP1439878A2 Method and apparatus for dispensing inhalator medicament |
| 07/28/2004 | EP1439863A2 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 07/28/2004 | EP1439841A2 Androgen receptor modulators and methods of use thereof |
| 07/28/2004 | EP1439840A1 Monobactam antibacterial compounds and methods of use thereof |
| 07/28/2004 | EP1439838A1 Macrolides containing pharmaceutical compositions |
| 07/28/2004 | EP1439837A1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 07/28/2004 | EP1439827A2 Inhalation of vapour of therapeutical substances |
| 07/28/2004 | EP1226244B1 Polypeptides with non-natural primary signalling motifs |
| 07/28/2004 | EP1175445B1 Specific antibodies and antibody fragments for tgfbeta1 |
| 07/28/2004 | EP1063968B1 Improved compositions for inhalation |
| 07/28/2004 | EP0927183B1 Spirocyclic metalloprotease inhibitors |